Geneva, Dec. 23 -- International Clinical Trials Registry received information related to the study (NCT07279558) titled 'Cannabidiol and Alcohol Use Disorder Phenotypes' on Dec. 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: University of Colorado, Denver
Condition:
Alcohol Use Disorder
Intervention:
Drug: Full-Spectrum Cannabidiol (CBD)
Drug: Broad-Spectrum Cannabidiol (CBD)
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: February 1, 2026
Target Sample Size: 180
Countries of Recruitment:
United States
To ...